首页> 外国专利> New partnership between 4 - 3 - (cis-hexahydrocycloopenta C pirol-2 (1H) - Il propoxi benzamida and the opponents of MFN receivers and recipe components containing MFN receivers

New partnership between 4 - 3 - (cis-hexahydrocycloopenta C pirol-2 (1H) - Il propoxi benzamida and the opponents of MFN receivers and recipe components containing MFN receivers

机译:4-[3-(顺式六氢环戊[C]吡咯2(1H)-II]丙氧嘧啶]苯甲酰胺与最惠国待遇接收者和含有最惠国待遇接收者的配方成分的反对者建立新的伙伴关系

摘要

The invention refers to the most favored nation receptor 4 - {3 - [cis-hexahydrocycliopedia [C] pirol-2 (1h-ii] proposxi] benzamida, or a salt added to an acceptable drug base or acid, and a new partnership for the treatment of cognitive impairment related to aging, namely memantina. In this partnership, 4 - {3 - [cis-hexahydro-ocyclopenta [C] pirol-2 (1H) - II] propoxi] benzoamines are used as an oxalato or a hydrochloride in doses of 2, 5 or 20 mg, while parathion is 10 or 20 mg.These compounds can be used in combination with one or more pharmaceutically acceptable precursor chemicals to treat these diseases. The formula of 4 - {3 - [cis-hexahydrocycloopenta [C] pirol-2 (1 (H) - II] proposxi] phenyltriamine is as follows:
机译:本发明涉及最受支持的国家受体4- {3- [顺式六氢环足动物[C] pirol-2(1h-ii] proposxi] benzamida),或添加到可接受的药物碱或酸中的盐,以及一种新的伙伴关系。在这种伙伴关系中,使用4- {3-[[顺式-六氢-环戊环[C] pirol-2(1H)-II]丙氧]苯甲胺]作为草酸根或盐酸盐。这些化合物可以与一种或多种药学上可接受的前体化学品联合使用,以治疗这些疾病,其剂量为2、5或20 mg,对硫磷为10或20 mg。分子式为4-{3-[顺式六氢环戊[C] pirol-2(1(H)-II]丙氧苯基三胺如下:

著录项

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号